Tasly Pharmaceutical (600535.SH): TDX105 Granules Receive Drug Clinical Trial Approval

Zhitong Finance APP News, Tianshi Pharmaceutical (600535.SH) announced that recently, the company received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration (hereinafter referred to as the "National Medical Products Administration") for TDX105 Granules.